BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12460356)

  • 21. The influence of urine osmolality and other easily detected parameters on the response to desmopressin in the management of monosymptomatic nocturnal enuresis in children.
    Sözübir S; Ergun G; Celik A; Ulman I; Avanoglu A
    Minerva Urol Nefrol; 2006 Jun; 58(2):207-12. PubMed ID: 16767075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Drugs or enuresis alarm can help more children stay dry at night. To wet oneself is distressing and taxing for self-confidence].
    Bengtsson B; Wassén C
    Lakartidningen; 2000 Nov; 97(47):5459-61. PubMed ID: 11192770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enuresis: prevalence, risk factors and urinary pathology among school children in Istanbul, Turkey.
    Gür E; Turhan P; Can G; Akkus S; Sever L; Güzelöz S; Cifçili S; Arvas A
    Pediatr Int; 2004 Feb; 46(1):58-63. PubMed ID: 15043666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical management of nocturnal enuresis.
    Kuwertz-Bröking E; von Gontard A
    Pediatr Nephrol; 2018 Jul; 33(7):1145-1154. PubMed ID: 28828529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating use of higher dose oxybutynin in combination with desmopressin for refractory nocturnal enuresis.
    Berkenwald A; Pires J; Ellsworth P
    J Pediatr Urol; 2016 Aug; 12(4):220.e1-6. PubMed ID: 27373215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence of reduced bladder capacity during nighttime in children with monosymptomatic nocturnal enuresis.
    Borg B; Kamperis K; Olsen LH; Rittig S
    J Pediatr Urol; 2018 Apr; 14(2):160.e1-160.e6. PubMed ID: 29174376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nocturnal enuresis and daytime wetting: a multicentric trial with oxybutynin and desmopressin.
    Caione P; Arena F; Biraghi M; Cigna RM; Chendi D; Chiozza ML; De Lisa A; De Grazia E; Fano M; Formica P; Garofalo S; Gramenzi R; von Heland M; Lanza P; Lanza T; Maffei S; Manieri C; Merlini E; Miano L; Nappo S; Pagliarulo A; Paolini Paoletti F; Pau AC; Porru D; Artibani W
    Eur Urol; 1997; 31(4):459-63. PubMed ID: 9187908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can urinary nerve growth factor and bladder wall thickness correlation in children have a potential role to predict the outcome of non-monosymptomatic nocturnal enuresis?
    Telli O; Samancı C; Sarıcı H; Hascıcek AM; Kabar M; Eroglu M
    J Pediatr Urol; 2015 Oct; 11(5):265.e1-5. PubMed ID: 26051999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination therapy with alarm and drugs for monosymptomatic nocturnal enuresis not superior to alarm monotherapy.
    Naitoh Y; Kawauchi A; Yamao Y; Seki H; Soh J; Yoneda K; Mizutani Y; Miki T
    Urology; 2005 Sep; 66(3):632-5. PubMed ID: 16140092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of primary nocturnal enuresis persisting into adulthood.
    Vandersteen DR; Husmann DA
    J Urol; 1999 Jan; 161(1):90-2. PubMed ID: 10037376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Desmopressin tablets in the treatment of severe nocturnal enuresis in adolescents.
    Stenberg A; Läckgren G
    Pediatrics; 1994 Dec; 94(6 Pt 1):841-6. PubMed ID: 7970999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Primary enuresis in children. Which treatment today?].
    Caione P; Nappo S; Capozza N; Minni B; Ferro F
    Minerva Pediatr; 1994 Oct; 46(10):437-43. PubMed ID: 7808364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced anti-diuretic response to desmopressin during wet nights in patients with monosymptomatic nocturnal enuresis.
    Tauris LH; Andersen RF; Kamperis K; Hagstroem S; Rittig S
    J Pediatr Urol; 2012 Jun; 8(3):285-90. PubMed ID: 21514237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined therapy of enuresis alarm and desmopressin in the treatment of nocturnal enuresis.
    Sukhai RN; Mol J; Harris AS
    Eur J Pediatr; 1989 Feb; 148(5):465-7. PubMed ID: 2646131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective randomized trial using laser acupuncture versus desmopressin in the treatment of nocturnal enuresis.
    Radmayr C; Schlager A; Studen M; Bartsch G
    Eur Urol; 2001 Aug; 40(2):201-5. PubMed ID: 11528199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined treatment with enuresis alarm and desmopressin for nocturnal enuresis.
    Bradbury MG; Meadow SR
    Acta Paediatr; 1995 Sep; 84(9):1014-8. PubMed ID: 8652952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of effects of treatment of primary nocturnal enuresis with oxybutynin plus desmopressin, desmopressin alone or imipramine alone: a randomized controlled clinical trial.
    Lee T; Suh HJ; Lee HJ; Lee JE
    J Urol; 2005 Sep; 174(3):1084-7. PubMed ID: 16094064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Results of a therapeutic strategy against monosymptomatic nocturnal enuresis].
    Rodríguez do Forno A; Ariceta Iraola G
    An Esp Pediatr; 2001 Jan; 54(1):38-43. PubMed ID: 11181193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The circadian defect in plasma vasopressin and urine output is related to desmopressin response and enuresis status in children with nocturnal enuresis.
    Rittig S; Schaumburg HL; Siggaard C; Schmidt F; Djurhuus JC
    J Urol; 2008 Jun; 179(6):2389-95. PubMed ID: 18433780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of desmopressin on renal water and solute handling in desmopressin resistant monosymptomatic nocturnal enuresis.
    Kamperis K; Rittig S; Radvanska E; Jørgensen KA; Djurhuus JC
    J Urol; 2008 Aug; 180(2):707-13; discussion 713-4. PubMed ID: 18554642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.